Home > Financial Ratios > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2017Mar2016
   EV/Core EBITDA(x) 24.3118.2430.428.269.00

What is the latest EV/Core EBITDA ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest EV/Core EBITDA ratio of SYNCOM FORMULATIONS (INDIA) is 24.31 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202424.31
Mar202318.24
Mar202230.42
Mar20178.26
Mar20169.00

How is EV/Core EBITDA of SYNCOM FORMULATIONS (INDIA) Trending?

Years EV/Core EBITDA % Change
Mar2024 24.31
33.28
Mar2023 18.24
-40.04
Mar2022 30.42
268.28
Mar2017 8.26
-8.22
Mar2016 9 -

Other Financial Ratios of SYNCOM FORMULATIONS (INDIA)


Compare EV/Core EBITDA ratio of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,692.9 Cr 5% -0.2% -35.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,197.0 Cr 0.9% -0.2% -12.5% Stock Analytics
DIVIS LABORATORIES ₹159,634.0 Cr 0.1% 0.4% 16.6% Stock Analytics
CIPLA ₹126,082.0 Cr 0.5% 3.8% -3.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,167.0 Cr NA -0.9% 4.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,783.0 Cr 2.8% 6.9% -2% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

5%

-0.2%

-35.9%

SENSEX

1%

2.1%

0.5%


You may also like the below Video Courses